1. A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy. (March 2021) Authors: Frazzoni, L.; Sikandar, U.; Mazzella, G.; Fuccio, L.; Bazzoli, F.; Brillanti, S.; Azzaroli, F. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon‐based therapy: FUNDAMENTAL, a Phase II trial. Issue 7 (21st November 2014) Authors: Buti, M.; Flisiak, R.; Kao, J.‐H.; Chuang, W.‐L.; Streinu‐Cercel, A.; Tabak, F.; Calistru, P.; Goeser, T.; Rasenack, J.; Horban, A.; Davis, G. L.; Alberti, A.; Mazzella, G.; Pol, S.; Orsenigo, R.; Brass, C. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 7(2015) Page Start: 596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical and virological characteristics of HIV and HCV co-infected versus HCV monoinfected patients: A real-life evaluation in the PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort. (10th February 2016) Authors: Colombatto, P.; Biliotti, E.; Palazzo, D.; Ciancio, A.; Del Pin, B.; Rizzo, V.; Brancaccio, G.; Pasetto, M.C.; Castelli, E.; Ieluzzi, D.; Franceschet, E.; Storato, S.; Margotti, M.; Castelli, E.; Palladini, S.; Amoruso, D.C.; Buggio, A.; Madonia, S.; Cerva, C.; Bartolozzi, D. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice. (10th February 2016) Authors: Conti, F.; Scuteri, A.; Vitale, G.; Lazzarini, G.; Porro, A.; Muratori, P.; Serio, I.; Buonfiglioli, F.; Badia, L.; Lanzi, A.; Mastroroberto, M.; Appolloni, L.; Morotti, M.; Morelli, M.C.; Foschi, F.G.; Verucchi, G.; Brillanti, S.; Crespi, C.; Lenzi, M.; Mazzella, G. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Durable response in the markers of cholestasis through 18 months of open-label extension with obeticholic acid in primary biliary cholangitis. (8th October 2016) Authors: Trauner, M.; Nevens, F.; Andreone, P.; Mazzella, G.; Strasser, S.; Bowlus, C.; Invernizzi, P.; Drenth, J.; Pockros, P.; Regula, J.; Floreani, A.; Hohenester, S.; Luketic, V.; Shiffman, M.; van Erpecum, K.; Vargas, V.; Vincent, C.; Hansen, B.; MacConell, L.; Marmon, T. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 3 Page Start: e236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Durable response in the markers of cholestasis through 24 months of open-label extension with obeticholic acid in Italian patients with primary biliary cholangitis. Issue 1 (16th February 2017) Authors: Andreone, P.; Floreani, A.; Invernizzi, P.; Mazzella, G.; Owens-Grillo, J.; Smoot Malecha, E.; MacConell, L. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Durable response in the markers of cholestasis through 36 months of open-label extension with obeticholic acid in Italian patients with primary biliary cholangitis. Issue 1 (February 2018) Authors: Andreone, P.; Floreani, A.; Invernizzi, P.; Mazzella, G.; Owens-Grillo, J.; Malecha, E. Smoot; MacConell, L. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study. (10th February 2016) Authors: Weimer, L.E.; Vinci, M.; Borgia, G.; Brunetto, M.; Sturace, L.; Gaeta, G.B.; Chemello, L.; Buggio, A.; Andreone, P.; Raimondo, G.; Filomia, R.; Persico, M.; Puoti, M.; Rumi, M.G.; Benedetti, A.; Fargion, S.; Ieluzzi, D.; Nardone, G.; Foti, G.; Ciancio, A. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. IL28 polymorphism and HCC after DAAs for chronic hepatitis C. Issue 1 (February 2018) Authors: Simili, A.; Mazzella, G.; Ravaioli, F.; Davide, F.; Bacchi-Reggiani, M.L.; Porro, A.; Bazzoli, F.; Azzaroli, F. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Issue 1 (February 2018) Authors: Gardini, A.C.; Foschi, F.G.; Conti, F.; Petracci, E.; Marisi, G.; Buonfiglioli, F.; Ravaioli, M.; Mazzella, G.; Muratori, P.; Lenzi, M.; Crespi, C.; Bolondi, L.; Badia, L.; Verucchi, G.; Vitale, G.; Vukotic, R.; Brillanti, S.; Andreone, P. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗